North America (U.S., Canada):
The North American market for biguanides is expected to witness significant growth during the forecast period. This growth can be attributed to the increasing prevalence of chronic diseases such as diabetes and obesity, which are driving the demand for biguanides as an effective treatment option. Furthermore, the rising healthcare expenditure and growing awareness about the benefits of biguanides among healthcare professionals and patients will also contribute to the market growth in this region.
Asia Pacific (China, Japan, South Korea):
In the Asia Pacific region, countries like China, Japan, and South Korea are expected to witness rapid growth in the biguanides market. This growth can be attributed to the increasing geriatric population, rising prevalence of chronic diseases, and improving healthcare infrastructure in these countries. Additionally, the growing focus on preventive healthcare and increasing healthcare expenditure are also expected to drive market growth in this region.
Europe (United Kingdom, Germany, France):
The European market for biguanides is projected to register steady growth in the coming years. This growth can be attributed to the presence of a well-established healthcare system, increasing adoption of advanced healthcare technologies, and rising awareness about the benefits of biguanides in managing chronic diseases. Moreover, the increasing prevalence of obesity and diabetes in countries like the United Kingdom, Germany, and France is expected to further fuel market growth in this region.